146 related articles for article (PubMed ID: 4109085)
1. Treatment of malignant lymphomas with bleomycin.
Kimura I; Onoshi T; Kunimasa I; Takano J
Cancer; 1972 Jan; 29(1):58-60. PubMed ID: 4109085
[No Abstract] [Full Text] [Related]
2. Treatment of malignant lymphomas with methyl ester of streptonigrin (NSC 45384).
Rivers SL; Whittington RM; Medrek TJ
Cancer; 1966 Oct; 19(10):1377-85. PubMed ID: 5337271
[No Abstract] [Full Text] [Related]
3. [Results obtained with the clinical use of adriamycin].
Esposito S; Taylor LA
Haematologica; 1971; 56(9):343-66. PubMed ID: 5004536
[No Abstract] [Full Text] [Related]
4. Bleomycin in the treatment of the advanced, resistant and recurrent lymphomata.
Garrett MJ; Smith JD
Ir Med J; 1976 Feb; 69(3):67-70. PubMed ID: 67107
[No Abstract] [Full Text] [Related]
5. [Comparative toxic and therapeutic effects of adriamycin and bleomycin in malignant lymphoma (author's transl)].
De Lena M; Beretta G
Tumori; 1972; 58(1):17-27. PubMed ID: 4134612
[No Abstract] [Full Text] [Related]
6. [Methylhydrazine in the therapy of malignant lymphopathies].
Beltrametti L; Almici C
Policlinico Prat; 1967 Jan; 74(3):82-5. PubMed ID: 4878309
[No Abstract] [Full Text] [Related]
7. Chemotherapy of the lymphomas.
Lacher MJ
Med Times; 1970 May; 98(5):96-102. PubMed ID: 4911076
[No Abstract] [Full Text] [Related]
8. Vincristine therapy of lymphomas and chronic lymphocytic leukemia.
Desal DV; Ezdinli EZ; Stutzman L
Cancer; 1970 Aug; 26(2):352-9. PubMed ID: 4916023
[No Abstract] [Full Text] [Related]
9. Bleomycin in the reticuloses.
European Organization for Research on the Treatment of Cancer, Co-Operative Group for Leukaemia and Reticulocytoses
Br Med J; 1972 Jan; 1(5795):285-6. PubMed ID: 4109401
[TBL] [Abstract][Full Text] [Related]
10. Treatment of the lymphomas.
DeVita VT; Canellos GP
Semin Hematol; 1972 Apr; 9(2):193-209. PubMed ID: 4111886
[No Abstract] [Full Text] [Related]
11. Treatment of advanced malignant lymphomas with bleomycin.
Rudders RA
Blood; 1972 Sep; 40(3):317-32. PubMed ID: 4115726
[No Abstract] [Full Text] [Related]
12. Vinblastine treatment of malignant lymphomas.
Klener P; Donner L; Neuwirtová R; Ort J
Neoplasma; 1971; 18(5):505-11. PubMed ID: 4940935
[No Abstract] [Full Text] [Related]
13. [Therapeutic progress and iatrogenic problems in malignant hemopathies].
Geib KR; Papazian R
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1977; 29(4):343-9. PubMed ID: 22916
[No Abstract] [Full Text] [Related]
14. Bleomycin: a clinical evaluation of the agent on its own or in combination with mitomycin C.
van Dyk JJ; Falkson G; Falkson HC
S Afr Med J; 1972 Dec; 46(49):1921-6. PubMed ID: 4120162
[No Abstract] [Full Text] [Related]
15. Comparison of chlorambucil and streptonigrin (NSC-45383) in the treatment of malignant lymphomas.
Kaung DT; Wittington RM; Spencer H; Patno ME
Cancer; 1969 Jun; 23(6):1280-3. PubMed ID: 4890442
[No Abstract] [Full Text] [Related]
16. Therapeutic effect and toxicity of adriamycin in patients with neoplastic disease.
Wang JJ; Cortes E; Sinks LF; Holland JF
Cancer; 1971 Oct; 28(4):837-43. PubMed ID: 4329505
[No Abstract] [Full Text] [Related]
17. A kinetically designed chemotherapeutic regimen for advanced refractory lymphoma patients.
Rossof AH; Kerr RO; Braine HG; Coltman CA
Med Pediatr Oncol; 1978; 4(2):133-9. PubMed ID: 78437
[TBL] [Abstract][Full Text] [Related]
18. Cardiac toxicity of daunorubicin.
Bonadonna G; Monfardini S
Lancet; 1969 Apr; 1(7599):837. PubMed ID: 4180385
[No Abstract] [Full Text] [Related]
19. [Effectiveness of polychemotherapeutic treatments of lymphoproliferative diseases].
Cajozzo A; Citarrella P; Carreca I; D'Eredità F
Haematologica; 1970; 55(7):465-70. PubMed ID: 4996520
[No Abstract] [Full Text] [Related]
20. Clinical results of treatment with E. coli L-asparaginase in adults with leukemia, lymphoma, and solid tumors.
Clarkson B; Krakoff I; Burchenal J; Karnofsky D; Golbey R; Dowling M; Oettgen H; Lipton A
Cancer; 1970 Feb; 25(2):279-305. PubMed ID: 4905154
[No Abstract] [Full Text] [Related]
[Next] [New Search]
